Binyan Sui
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Health technology assessment and medical insurance access for rare disease drugs in China: A policy review with quantitative insights from publicly available data.
Journal: Intractable & rare diseases research
Published: November 18, 2025
Economic Burden and Health-Related Quality of Life Among Children With Achondroplasia in China: A Cross-Sectional Study.
Journal: Value in health regional issues
Published: August 06, 2025
A guideline for economic evaluations of vaccines and immunization programs in China.
Journal: Human vaccines & immunotherapeutics
Published: October 26, 2022
Assessment of health-related quality of life in patients with spina muscular atrophy in China.
Journal: Intractable & rare diseases research
Published: August 25, 2022
Budget Impact Analysis of Nusinersen for Spinal Muscular Atrophy in China.
Journal: Value in health regional issues
Published: May 05, 2022
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
Journal: International journal of health policy and management
Published: October 13, 2021
Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
Journal: International journal of technology assessment in health care
Published: September 15, 2020
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026